| CTRI Number |
CTRI/2025/03/081614 [Registered on: 04/03/2025] Trial Registered Prospectively |
| Last Modified On: |
27/02/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Pushkarmoola and Erandamoolas comparative effectiveness as an add on therapy for tuberculous plueral effusion |
|
Scientific Title of Study
|
Comparative Clinical Efficacy Of Pushkarmoola (Inula racemosa Hook.f) And Its Pratinidhi Dravya Erandamoola (Ricinus communis L.)As An Add On Therapy In Tuberculous Pleural Effusion. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr. Nupoorkumari A Patel |
| Designation |
MD Scholar |
| Affiliation |
Government Ayurved College and Hospital, Vadodara |
| Address |
Government Ayurved College and Hospital, Outside Panigate, Opp. Panigate Depot, Vadodara, Gujarat 390019
Vadodara GUJARAT 390019 India |
| Phone |
9624148759 |
| Fax |
|
| Email |
nupoor28patel@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Suman Singh |
| Designation |
Assistant professor |
| Affiliation |
Government Ayurved College and hospital, Vadodara |
| Address |
Government Ayurved College and Hospital Outside Panigate, Opp. Panigate Depot, Vadodara, Gujarat 390019
Vadodara GUJARAT 390019 India |
| Phone |
95101722024 |
| Fax |
|
| Email |
snghsmn@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DrAnand Patel |
| Designation |
Assistant professor |
| Affiliation |
GMERS Medical College and hospital, Gotri, Vadodara |
| Address |
Dept. of Pulmonary medicine, GMERS Medical College and hospital, Gotri, Vadodara 391101
Vadodara GUJARAT 391101 India |
| Phone |
9879771079 |
| Fax |
|
| Email |
dranandkpatel@gmail.com |
|
|
Source of Monetary or Material Support
|
| Government Ayurved college and Hospital, Ajwa road, Dhanwantari marg,Panigate, Vadodara, 390019 |
|
|
Primary Sponsor
|
| Name |
Government Ayurved college and Hospital,Vadodara |
| Address |
Government Ayurveda college and Hospital, Outside Panigate, Opp. Panigate Depot, Vdodara,Gujarat 390019 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anand Patel |
GMERS, Medical College and Hospital Gotri, Vadodara |
Opd No.206,Dept. of Pulmonary medicine, GMERS Medical College and hospital, Gotri, Vadodara 391101 Vadodara GUJARAT |
09879771079
dranandkpatel@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Government Ayurved College and Hospital, Vadodara |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:J90||Pleural effusion, not elsewhere classified. Ayurveda Condition: PARSVARUJAH/PARSVASULAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Pushkarmoola, Reference: Vrindamadhava 31/12, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: tds, Bhaishajya Kal: Pragbhakta, Duration: 4 Weeks, anupAna/sahapAna: Yes(details: Honey), Additional Information: - | | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Erandamoola, Reference: -, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 4 Weeks, anupAna/sahapAna: Yes(details: honey), Additional Information: - | | 3 | Comparator Arm (Non Ayurveda) | | - | standard | AKT as per standard protocol |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
Diagnosed case of mild and moderate pleural effusion in Tuberculosis |
|
| ExclusionCriteria |
| Details |
Pleural effusion associated with malignancy, cirrhosis of liver, HIV.
Patient with major systemic illness which intervened the course of treatment
Pregnant and lactating women |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
Primary- Reduction in symptoms
|
4week
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Secondary- non recurrence of condition and improvement in quality of life |
1 week |
|
|
Target Sample Size
|
Total Sample Size="45" Sample Size from India="45"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
18/04/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is randomized clinical trial to comparative clinical efficacy of Pushkaramoola and its pratinidhi dravya Erandamoola as an add on therapy in Tuberculous Pleural effusion. Total 45 patient will enrolled in present study divided in three groups on the basis of computer generated randomization. In this study churna of Pushkarmoola and Kwath of Erandamoola with sahapana of Honey thrice in a Day for Four week. Follow up for 1 week. Clinical data obtained will e summarized at the end of study. Conclusion will e made after the statistical analysis of data. |